1. Li, Rui, Xu, Zhaojie, Zhao, Ding, Zhang, Zhenhua, Song, Jijun. . [Analysis of MCCC2 gene variant in a pedigree affected with 3-methylcrotonyl coenzyme A carboxylase deficiency]. In Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 38, 74-77. doi:10.3760/cma.j.cn511374-20200110-00021. https://pubmed.ncbi.nlm.nih.gov/33423264/
2. Cheng, Yi, Chen, Peichun, Yu, Zinan, Miao, Haixia, Huang, Xinwen. 2023. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency in Zhejiang province, China. In Clinica chimica acta; international journal of clinical chemistry, 542, 117266. doi:10.1016/j.cca.2023.117266. https://pubmed.ncbi.nlm.nih.gov/36822454/
3. Dai, Wenxin, Feng, Huiying, Lee, Dongwon. 2020. MCCC2 overexpression predicts poorer prognosis and promotes cell proliferation in colorectal cancer. In Experimental and molecular pathology, 115, 104428. doi:10.1016/j.yexmp.2020.104428. https://pubmed.ncbi.nlm.nih.gov/32205097/
4. He, Jiancheng, Yi, Jianfeng, Ji, Li, Chen, Yu, Xue, Wanjiang. 2024. ECHDC2 inhibits the proliferation of gastric cancer cells by binding with NEDD4 to degrade MCCC2 and reduce aerobic glycolysis. In Molecular medicine (Cambridge, Mass.), 30, 69. doi:10.1186/s10020-024-00832-9. https://pubmed.ncbi.nlm.nih.gov/38783226/
5. Liu, Yu, Yuan, Zonghuai, Song, Chuanwei. 2019. Methylcrotonoyl-CoA carboxylase 2 overexpression predicts an unfavorable prognosis and promotes cell proliferation in breast cancer. In Biomarkers in medicine, 13, 427-436. doi:10.2217/bmm-2018-0475. https://pubmed.ncbi.nlm.nih.gov/30895811/
6. Feng, Cheng'ao, Fan, Yu, Gao, Hongwei, Zhang, Bowen, Lu, Xiaojie. 2025. Expression of MCCC2 in glioma cells and preliminary verification of poor prognosis. In Biomarkers in medicine, 19, 205-213. doi:10.1080/17520363.2025.2473131. https://pubmed.ncbi.nlm.nih.gov/40035348/
智鼠故事 
